Neutrophil NADPH oxidase and apoptosis assays

TB Tiffany Y. Borbón
BS Breanna M. Scorza
GC Gwendolyn M. Clay
FQ Fellipe Lima Nobre de Queiroz
AS Alan J. Sariol
JB Jayden L. Bowen
YC Yani Chen
BZ Bayan Zhanbolat
CP Corey P. Parlet
DV Diogo G. Valadares
SC Suzanne L. Cassel
WN William M. Nauseef
AH Alexander R. Horswill
FS Fayyaz S. Sutterwala
MW Mary E. Wilson
request Request a Protocol
ask Ask a question
Favorite

Single cells suspensions were obtained one day p.i. from mouse ears as described above. Cells were surface stained with Brilliant Violet 711 anti-Ly6G, Brilliant Violet 421 anti-CD45 clone 30-F11, and APC-Cy7 anti-CD11b clone M1/70 from Biolegend. To assess the ability of neutrophils to activate the phagocyte NADPH oxidase, cells were incubated in PBS with 100 ng/mL of PMA (Sigma Aldrich) and 10 μM dihydrorhodamine 123 (DHR123, Sigma Aldrich) for 15 minutes at 37°C, 5% CO2, and then washed in PBS and analyzed by flow cytometry. To assay for apoptosis, cell suspensions were resuspended in 100 μL Annexin V binding buffer (Biolegend) and incubated with 5 μL of APC Annexin V (Biolegend) for 10–15 min at room temperature in the dark. Within 10 minutes prior to analysis by flow cytometry, 10 μL of Propidium Iodide Staining Solution (Biolegend) was added to each sample.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A